Table 1.
Disease | Repeat Sequence | Repeat Length | RNA structure | Location of Repeat | Primary Toxicity (RNA vs Protein) |
---|---|---|---|---|---|
Myotonic Dystrophy Type 1 (DM1) | CTG | Unaffected: 5–38 Affected: 50–5000 |
Single or multi-hairpin with U/U loops (Mooers et al., 2005; Kumar et al., 2011; Cruchten, Wieringa, & Wansink, 2019) | 3’ UTR of DMPK gene (Brook et al.,1992) | RNA |
Myotonic Dystrophy Type 2 (DM2) | CCTG | Unaffected: ~26 Affected: 75–11,000 |
Hairpin with CU/UC loops (Dere et al., 2004; Childs-Disney et al., 2013) | Intron 1 of CNBP gene (Liquori et al., 2001) | RNA |
Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) | CGG | Unaffected: 6–54 Affected: 55–200 |
Hairpins with potential G-quadruplex (Handa et al., 2003; Blice-Baum & Mihailescu, 2014) | 5’ UTR of FMR1 gene (Kremer et al., 1991) | RNA |
Amyotrophic Lateral Sclerosis (ALS) | GGGGCC | Unaffected: ≤11 Affected: >30 and up to thousands |
Hairpins and stable G-quadruplexes (Su et al., 2014; Balendra & Isaacs, 2018) | Intron 1 of C9orf72 gene (DeJesus-Hernandez et al., 2011) | Toxic protein production, RNA toxicity, and protein loss of function |